Ye Xu

834 total citations · 1 hit paper
22 papers, 589 citations indexed

About

Ye Xu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ye Xu has authored 22 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ye Xu's work include Colorectal and Anal Carcinomas (4 papers), Extracellular vesicles in disease (3 papers) and Colorectal Cancer Screening and Detection (3 papers). Ye Xu is often cited by papers focused on Colorectal and Anal Carcinomas (4 papers), Extracellular vesicles in disease (3 papers) and Colorectal Cancer Screening and Detection (3 papers). Ye Xu collaborates with scholars based in China and United States. Ye Xu's co-authors include Yibin Wu, Ping Wei, Dawei Li, Xinxiang Li, Sanjun Cai, Yushuai Mi, Yanzi Gu, Senlin Zhao, Zhengxiang Zhang and Binbin Zheng-Lin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Langmuir.

In The Last Decade

Ye Xu

18 papers receiving 583 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Highly‐metastatic colorectal cancer cell released miR‐181a‐5p‐rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment

2022 148 citations Senlin Zhao, Yushuai Mi et al. Journal of Extracellular Vesicles profile →

Peers

Countries citing papers authored by Ye Xu

Since Specialization

Citations

This map shows the geographic impact of Ye Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Xu more than expected).

Fields of papers citing papers by Ye Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Xu. The network helps show where Ye Xu may publish in the future.

Co-authorship network of co-authors of Ye Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Xu. A scholar is included among the top collaborators of Ye Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Xu. Ye Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chromosome-level assemblies of the White bream Parabramis pekinensis 2025 ·PubMed ·(unknown), Xinhui Zhang, (unknown), Zhijing Yang, Ye Xu, (unknown), (unknown)	0
2	Single‐Atom Enzymes: From Evolutionary Insights, Precision Engineering to Breakthroughs in Biomedical Applications 2025 ·Small ·Ye Xu, (unknown), Xueliang Liu, (unknown), Zhejie Chen, (unknown), Jiabei Li, Yu Yang, Weihong Tan	4
3	Bioinformatics and experimental approach reveal potential prognostic and immunological roles of key mitochondrial metabolism-related genes in cervical cancer 2025 ·Frontiers in Oncology ·Qing Huang, Ye Xu, Huiping Li, Ting Zhang	0
4	Anlotinib versus bevacizumab added to standard first-line chemotherapy among patients with RAS/BRAF wild-type, unresectable metastatic colorectal cancer: A multicenter, prospective, randomised, phase 3 clinical trial (ANCHOR trial). 2025 ·Journal of Clinical Oncology ·(unknown), Yue Liu, (unknown), Rongbo Lin, Xiaobing Chen, Junye Wang, (unknown), Xiujuan Qu, Yunfeng Li, Jiayi Li, Weisheng Zhang, Yong Mao, (unknown), (unknown), Ying Cheng, Jian Lei, Ye Xu, Yi Jiang, (unknown), (unknown), (unknown)	0
5	Highly‐metastatic colorectal cancer cell released miR‐181a‐5p‐rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment breakdown → 2022 ·Journal of Extracellular Vesicles ·Senlin Zhao, Yushuai Mi, Binbin Zheng-Lin, Ping Wei, Yanzi Gu, Zhengxiang Zhang, Ye Xu, Sanjun Cai, Xinxiang Li, Dawei Li	148
6	Grade G2 Rectal Neuroendocrine Tumor Is Much More Invasive Compared With G1 Tumor 2021 ·Frontiers in Oncology ·Yiwei Li, Yiping He, Fangqi Liu, Junjie Peng, Sanjun Cai, Ye Xu, Minghe Wang	11
7	Correction to: Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer 2021 ·Journal of Hematology & Oncology ·Senlin Zhao, Yushuai Mi, Bingjie Guan, Binbin Zheng-Lin, Ping Wei, Yanzi Gu, Zhengxiang Zhang, Sanjun Cai, Ye Xu, Xinxiang Li, Xuefeng He, Xinyang Zhong, Guichao Li, Zhiyu Chen, Dawei Li	13
8	Comparison Between Familial Colorectal Cancer Type X and Lynch Syndrome: Molecular, Clinical, and Pathological Characteristics and Pedigrees 2020 ·Frontiers in Oncology ·Yun Xu, Cong Li, Yuqin Zhang, Tianan Guo, Congcong Zhu, Ye Xu, Fangqi Liu	8
9	Integrated bioinformatics analysis of expression and gene regulation network of COL12A1 in colorectal cancer 2020 ·Cancer Medicine ·Yibin Wu, Ye Xu	46
10	Exosomes derived miR-454-3P to promote the progression of colorectal cancer via MIER1-mediated Notch signaling activation. 2019 ·Journal of Clinical Oncology ·Dawei Li, (unknown), Ye Xu, Xinxiang Li, Sanjun Cai	0
11	The FOXC1/FBP1 signaling axis promotes colorectal cancer proliferation by enhancing the Warburg effect 2018 ·Oncogene ·Qingguo Li, Ping Wei, Jitao Wu, Meng Zhang, Guichao Li, Yaqi Li, Ye Xu, Xinxiang Li, Dacheng Xie, Sanjun Cai, Keping Xie, Dawei Li	49
12	Temporary Diverting Stoma Improves Recovery of Anastomotic Leakage after Anterior Resection for Rectal Cancer 2017 ·Scientific Reports ·Yuchen Wu, Hongtu Zheng, Tianan Guo, (unknown), Fangqi Liu, Ye Xu	20
13	FGF‐1/‐3/FGFR4 signaling in cancer‐associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP‐7 2015 ·Cancer Science ·(unknown), Kun Shang, Huan Chen, Fei Ding, Zhen Wang, Chen Liang, Ye Xu, Menghong Sun, Ying-Yi Li	89
14	Effect of thoracic epidural anaesthesia on serum vascular endothelial growth factor C and cytokines in patients undergoing anaesthesia and surgery for colon cancer 2014 ·British Journal of Anaesthesia ·Ye Xu, (unknown), Yu Zhu, (unknown), Changhong Miao	36
15	Clinicopathological and genetic features of Chinese hereditary nonpolyposis colorectal cancer (HNPCC) 2014 ·Medical Oncology ·Fangqi Liu, Yang Li, Xiaoyan Zhou, Weiqi Sheng, Sanjun Cai, Lei Liu, Nan Peng, Ye Xu	16
16	Risk Factors of Synchronous Inguinal Lymph Nodes Metastasis for Lower Rectal Cancer Involving the Anal Canal 2014 ·PLoS ONE ·Renjie Wang, Peng Wu, Debing Shi, Hongtu Zheng, Liyong Huang, (unknown), Ye Xu, Sanjun Cai, Guoxiang Cai	10
17	Validation of TPX2 as a novel prognostic marker for malignant progression and metastasis of colon cancer. 2013 ·Journal of Clinical Oncology ·Ping Wei, Dawei Li, Ye Xu, Sanjun Cai	1
18	DRUMS: A human disease related unique gene mutation search engine 2011 ·Human Mutation ·Zuofeng Li, (unknown), (unknown), Ye Xu, Xin Zhao, (unknown), Lei Liu, Xiaoyan Zhang	8
19	c-kit gene mutation and CD117 expression in human anorectal melanomas 2011 ·Human Pathology ·Shujuan Ni, Dan Huang, Xiaochen Chen, Jiaying Huang, Yunyi Kong, Ye Xu, Du Xiang, Weiqi Sheng	34
20	Prognostic Significance of the Metastatic Lymph Node Ratio in Node-Positive Rectal Cancer 2008 ·Annals of Surgical Oncology ·Junjie Peng, Ye Xu, (unknown), Ji Zhu, Minghe Wang, Guoxiang Cai, Weiqi Sheng, Sanjun Cai	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact